中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2010年
7期
906-907
,共2页
刘波%越太迁%邓世全%罗亚%靳明林
劉波%越太遷%鄧世全%囉亞%靳明林
류파%월태천%산세전%라아%근명림
直肠肿瘤%吻合术%外科%结肠系膜
直腸腫瘤%吻閤術%外科%結腸繫膜
직장종류%문합술%외과%결장계막
Rectal neoplasms%Anastomosis,surgical%Mesocolon
目的 探讨全直肠系膜切除(TME)在低位直肠癌保肛根治术中的临床应用价值.方法 对45例低位直肠癌患者采用Heald法施行全TME保肛术的临床资料进行回顾性分析.结果 45例中无死亡病例;术后吻合口漏2例,吻合口出血2例;41例患者获随访,随访率为91.1%;吻合口局部肿瘤复发4例,复发率8.9%,5年生存率70.5%.结论 低位直肠癌的保肛要完全遵照全直肠系膜切除原则,必须严格选择病例,保证手术效果,最大限度保留排便功能;吻合13漏是低位直肠癌保肛术主要并发症之一;不主张不管肿瘤的分期而一味追求保留肛门.
目的 探討全直腸繫膜切除(TME)在低位直腸癌保肛根治術中的臨床應用價值.方法 對45例低位直腸癌患者採用Heald法施行全TME保肛術的臨床資料進行迴顧性分析.結果 45例中無死亡病例;術後吻閤口漏2例,吻閤口齣血2例;41例患者穫隨訪,隨訪率為91.1%;吻閤口跼部腫瘤複髮4例,複髮率8.9%,5年生存率70.5%.結論 低位直腸癌的保肛要完全遵照全直腸繫膜切除原則,必鬚嚴格選擇病例,保證手術效果,最大限度保留排便功能;吻閤13漏是低位直腸癌保肛術主要併髮癥之一;不主張不管腫瘤的分期而一味追求保留肛門.
목적 탐토전직장계막절제(TME)재저위직장암보항근치술중적림상응용개치.방법 대45례저위직장암환자채용Heald법시행전TME보항술적림상자료진행회고성분석.결과 45례중무사망병례;술후문합구루2례,문합구출혈2례;41례환자획수방,수방솔위91.1%;문합구국부종류복발4례,복발솔8.9%,5년생존솔70.5%.결론 저위직장암적보항요완전준조전직장계막절제원칙,필수엄격선택병례,보증수술효과,최대한도보류배편공능;문합13루시저위직장암보항술주요병발증지일;불주장불관종류적분기이일미추구보류항문.
Objective To investigate the clinical value of total mesorectal excision (TEM) in anal preservation operation to low rectal cancer patients. Methods The data of 45 low rectal cancer patients underwent TME anal preservation operation in hospital were analyzed retrospectively. Results No patient died. 2 cases stomal leak and 2 cases stomal bleeding were found after operation. Stomal recurrence occurred in 4 cases with the recurrence rate of 8.9%. The 5-year survival rate was 70. 5%. Conclusions TEM operation principle should be stricktly complied in anal preservation operation to low rectal carcinoma. The stomal leak is the most common complication. Pursuing anal preservation operation regardless of tumour stage is not advocated.